The overall goals of this proposal are to understand the cellular and molecular mechanisms that govern lung tissue injury and repair. To accomplish this goal, two different cell lineages (alveolar epithelium and fibroblasts) will serve as models of developmentally regulated and injury induced changes in specific genes, the products of which play a role in inflammation and tissue repair. To accomplish these goals, we will: a) ascertain the pattern and mechanisms of change in complement gene expression during differentiation of embryonic lung cells to alveolar and b) elucidate the mechanisms of cytokine and growth factor regulation/counter-regulation of complement gene expression in fibroblasts. The complement genes (C2, factor B, C3, C4) provide a useful window into the developmental and tissue injury dependent process because they are expressed in both cell lineages, developmental and cytokine induced regulation, and growth factor counter-regulation have already been recognized, and these complement proteins play a role in host defenses against infection. Cellular and molecular biological methods will be utilized to address these questions. The proposed studies offer the promise of understanding pulmonary tissue injury, inflammation and repair to allow development of systematic approaches to a variety of pulmonary disorders as diverse as bronchopulmonary dysplasia and bronchiolitis obliterans, among others.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL037591-08
Application #
2218511
Study Section
Lung Biology and Pathology Study Section (LBPA)
Project Start
1986-04-01
Project End
1997-06-30
Budget Start
1994-07-01
Budget End
1995-06-30
Support Year
8
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Washington University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Hamvas, A; Nogee, L M; Mallory Jr, G B et al. (1997) Lung transplantation for treatment of infants with surfactant protein B deficiency. J Pediatr 130:231-9
Matsumoto, M; Fukuda, W; Circolo, A et al. (1997) Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc Natl Acad Sci U S A 94:8720-5
Ernst, S C; Circolo, A; Davis 3rd, A E et al. (1996) Impaired production of both normal and mutant C1 inhibitor proteins in type I hereditary angioedema with a duplication in exon 8. J Immunol 157:405-10
Katz, Y; Gur, S; Aladjem, M et al. (1995) Synthesis of complement proteins in amnion. J Clin Endocrinol Metab 80:2027-32
Wetsel, R A (1995) Expression of the complement C5a anaphylatoxin receptor (C5aR) on non-myeloid cells. Immunol Lett 44:183-7
Wang, X; Fleischer, D T; Whitehead, W T et al. (1995) Inherited human complement C5 deficiency. Nonsense mutations in exons 1 (Gln1 to Stop) and 36 (Arg1458 to Stop) and compound heterozygosity in three African-American families. J Immunol 154:5464-71
Haviland, D L; McCoy, R L; Whitehead, W T et al. (1995) Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J Immunol 154:1861-9
Colten, H R (1995) Molecular and cellular pathobiology of pulmonary surfactant protein B deficiency. Proc Assoc Am Physicians 107:334-9
Akama, H; Johnson, C A; Colten, H R (1995) Human complement protein C2. Alternative splicing generates templates for secreted and intracellular C2 proteins. J Biol Chem 270:2674-8
Hamvas, A; Cole, F S; deMello, D E et al. (1994) Surfactant protein B deficiency: antenatal diagnosis and prospective treatment with surfactant replacement. J Pediatr 125:356-61

Showing the most recent 10 out of 33 publications